moxisylyte has been researched along with Remission, Spontaneous in 2 studies
Moxisylyte: An alpha-adrenergic blocking agent that is used in Raynaud's disease. It is also used locally in the eye to reverse the mydriasis caused by phenylephrine and other sympathomimetic agents. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1312)
Remission, Spontaneous: A spontaneous diminution or abatement of a disease over time, without formal treatment.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Haddock, AM | 1 |
| Patel, KR | 2 |
| Alston, WC | 2 |
| Kerr, JW | 2 |
2 other studies available for moxisylyte and Remission, Spontaneous
| Article | Year |
|---|---|
Response of lymphocyte guanyl cyclase to propranolol, noradrenaline, thymoxamine, and acetylcholine in extrinsic bronchial asthma.
Topics: Acetylcholine; Adolescent; Adult; Asthma; Bronchi; Cyclic AMP; Drug Synergism; Female; Guanylate Cyc | 1975 |
Response of leucocyte adenyl cyclase to isoprenaline and effect of alpha-blocking drugs in extrinsic bronchial asthma.
Topics: Acute Disease; Adenylyl Cyclases; Adolescent; Adrenergic alpha-Antagonists; Adult; Asthma; Drug Comb | 1974 |